Literature DB >> 24907168

Prevalence of obesity and systemic hypertension among diabetes mellitus patients attending an out-patient diabetes clinic in a Ghanaian Teaching Hospital.

Victor Mogre1, Robert Abedandi2, Zenabankara S Salifu2.   

Abstract

AIMS: Diabetes Mellitus is now a prevalent disease in both developed and developing countries. Overweight/obesity and hypertension are potential modifiable risk factors for diabetes mellitus and persist during the course of the disease. This study was aimed at reporting the prevalence of overweight/obesity and systemic hypertension and their association to blood glucose levels in persons with diabetes mellitus attending a diabetic clinic in Ghanaian Teaching Hospital.
MATERIALS AND METHODS: This cross-sectional study was conducted among 100 previously diagnosed diabetes mellitus patients attending a diabetic clinic at the Tamale Teaching Hospital, Ghana. Anthropometric variables of age, weight and height were measured with appropriate instruments, computed into BMI and classified according to WHO classifications. Systolic and diastolic blood pressures were measured by an appropriate instrument and classified by WHO standards. Fasting plasma glucose levels of the study participants were recorded from their personal health folder. All data was analysed by GraphPad prism version 5.
RESULTS: In general, 7.0% of the participants were underweight and 32.0% were overweight or obese. The mean±SD weight, height and BMI of the participants were 67.53±13.32, 1.68±0.12 and 24.18±5.32. Twenty-one percent of the studied participants were hypertensive. Mean±SD fasting plasma glucose of 7.94±2.82 was observed among the diabetic patients. As the prevalence of hyperglycaemia was higher among patients aged ≤40 years (88.9% vs. 75.8%), normoglycaemia (11.1% vs. 24.2%) was higher among those over 40 years. The differences were not significant. The prevalence of hyperglycaemia was significantly higher in participants with overweight/obese (0.0% vs. 41.6%, p<0.0001) than those with underweight (26.1% vs. 1.3%, p=0.0005) and normal weight (73.9% vs. 57.1%, p=0.2228).
CONCLUSION: A high prevalence of overweight/obesity and systemic hypertension was found. Hyperglycaemia was more prevalent among overweight/obese participants.
Copyright © 2014 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Ghana; Hypertension; Obesity; Overweight; Tamale

Mesh:

Substances:

Year:  2014        PMID: 24907168     DOI: 10.1016/j.dsx.2014.04.036

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  5 in total

1.  Fasting plasma glucose and lipid profiles of diabetic patients improve with aerobic exercise training.

Authors:  Benjamin Asuako; Monday O Moses; Benjamin A Eghan; Peter A Sarpong
Journal:  Ghana Med J       Date:  2017-09

2.  Correlates and Predictors of Increasing Waist Circumference in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Authors:  Victor Mogre; Robert Abedandi; Zenabankara S Salifu
Journal:  Int Sch Res Notices       Date:  2014-09-15

3.  Association between Periodontal Condition and Nutritional Status of Brazilian Adolescents: A Population-based Study.

Authors:  Alessandro L Cavalcanti; Ianny A Ramos; Andreia M R Cardoso; Liege Helena F Fernandes; Amanda S Aragão; Fábio G Santos; Yêska P C Aguiar; Danielle F Carvalho; Carla C M Medeiros; Renata De S C Soares; Ricardo D Castro
Journal:  Iran J Public Health       Date:  2016-12       Impact factor: 1.429

4.  Prevalence and associated factors of overweight/obesity among type2 diabetic outpatients in Southwest Ethiopia.

Authors:  Daba Abdissa; Abebe Dukessa; Alemayeu Babusha
Journal:  Heliyon       Date:  2021-02-24

5.  Magnitude of overweight and associated factors among type 2 diabetes mellitus patients at Mekelle public hospitals, Tigray, Ethiopia: a cross-sectional study.

Authors:  Kbrom Gemechu Kiros; Gebre Yitayih Abyu; Desta Siyoum Belay; Mekonnen Haftom Goyteom; Tensay Kahsay Welegebriel
Journal:  BMC Res Notes       Date:  2019-11-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.